Literature DB >> 22640903

Early detection of familial Creutzfeldt-Jakob disease on diffusion-weighted imaging before symptom onset.

Yuka Terasawa1, Koji Fujita, Yuishin Izumi, Ryuji Kaji.   

Abstract

Familial Creutzfeldt-Jakob disease (CJD) with V180I shows different clinical characteristics from classical CJD and is difficult to diagnose in the early stage. We report a CJD180 patient in whom results of diffusion-weighted imaging (DWI) led us to suspect CJD before symptoms started. A 68-year-old woman presented to our hospital with headache and nausea and underwent magnetic resonance imaging. DWI showed cortical hyperintensity. Three months later, cognitive function started to decline and CJD180 was diagnosed following genetic examination. In the early stage, ADC values were not decreased and single positron emission computed tomography demonstrated a decreased pattern like Alzheimer disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22640903     DOI: 10.1016/j.jns.2012.04.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt-Jakob disease.

Authors:  Federico Verde; Nicola Ticozzi; Stefano Messina; Narghes Calcagno; Floriano Girotti; Luca Maderna; Fabio Moda; Elisa Scola; Andrea Falini; Fabrizio Tagliavini; Vincenzo Silani
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

2.  Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Zeev Nitsan; Shmuel Appel; Chen Hoffmann; Hanna Rosenmann; Esther Kahana; Hedok Lee
Journal:  J Neurol       Date:  2014-12-19       Impact factor: 4.849

3.  Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging.

Authors:  Alberto Bizzi; Riccardo Pascuzzo; Janis Blevins; Marina Grisoli; Raffaele Lodi; Marco E M Moscatelli; Gianmarco Castelli; Mark L Cohen; Lawrence B Schonberger; Aaron Foutz; Jiri G Safar; Brian S Appleby; Pierluigi Gambetti
Journal:  JAMA Neurol       Date:  2020-09-01       Impact factor: 18.302

4.  An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.

Authors:  Leonardo Iaccarino; Rosa Maria Moresco; Luca Presotto; Orso Bugiani; Sandro Iannaccone; Giorgio Giaccone; Fabrizio Tagliavini; Daniela Perani
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

5.  Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.

Authors:  Sonia M Vallabh; Eric Vallabh Minikel; Victoria J Williams; Becky C Carlyle; Alison J McManus; Chase D Wennick; Anna Bolling; Bianca A Trombetta; David Urick; Chloe K Nobuhara; Jessica Gerber; Holly Duddy; Ingolf Lachmann; Christiane Stehmann; Steven J Collins; Kaj Blennow; Henrik Zetterberg; Steven E Arnold
Journal:  BMC Med       Date:  2020-06-18       Impact factor: 8.775

6.  Early Diagnosis of V180I Genetic Creutzfeldt-Jakob Disease at the Preserved Cognitive Function Stage.

Authors:  Yutaro Suzuki; Atsuhiko Sugiyama; Mayumi Muto; Katsuya Satoh; Tetsuyuki Kitamoto; Satoshi Kuwabara
Journal:  Cureus       Date:  2022-03-21

7.  Significance of Cortical Ribboning as a Biomarker in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease.

Authors:  Yasuhiro Hamada; Kazushi Deguchi; Kisaki Tachi; Makoto Kita; Wakako Nonaka; Tadayuki Takata; Hideki Kobara; Tetsuo Touge; Katsuya Satoh; Tsutomu Masaki
Journal:  Intern Med       Date:  2022-02-19       Impact factor: 1.282

8.  Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene.

Authors:  Temu Qina; Nobuo Sanjo; Masaki Hizume; Maya Higuma; Makoto Tomita; Ryuichiro Atarashi; Katsuya Satoh; Ichiro Nozaki; Tsuyoshi Hamaguchi; Yosikazu Nakamura; Atsushi Kobayashi; Tetsuyuki Kitamoto; Shigeo Murayama; Hiroyuki Murai; Masahito Yamada; Hidehiro Mizusawa
Journal:  BMJ Open       Date:  2014-05-16       Impact factor: 2.692

9.  A patient with spastic paralysis finally diagnosed as V180I genetic Creutzfeldt-Jakob disease 9 years after onset.

Authors:  Taichi Nomura; Ikuko Iwata; Ryoji Naganuma; Masaaki Matsushima; Katsuya Satoh; Tetsuyuki Kitamoto; Ichiro Yabe
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.